Research Initiatives

Mental Health/Cognitive Research:

• Down syndrome and neuropsychiatric disorders (children and adults)
• Down syndrome and sleep disorders

Clinical Trials:

• Double-Blind, Placebo-Controlled Study of FDA-Approved Drug, Rivastigmine
• A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Investigate Safety and Tolerability of RO5186582 with Roche Pharmaceuticals

Genetics of Down Syndrome -- The Phenotype Project:

• Heart Project (AV Canal)
• Facial Morphometry
• Usefulness of Computer-Based Testing to Measure Visual Memory and Movement

Current Research Studies:

• Rivastigmine Study
• Roche GABA Study

For More Information:

For questions or more information about our center’s research initiatives, please contact Kay Taylor at taylork@kennedykrieger.org or Cathleen Weadon at Weadon@kennedykrieger.org.